NET LOSS PER SHARE

6 Months Ended

Jun. 30, 2023

The following table sets forth the computation of basic and diluted net loss per share attributable to common stockholders for the three and six months ended June 30 (in thousands, except for per share amounts):


	Three Months Ended June 30,				Six Months Ended June 30,
	2023		2022		2023		2022
Loss from continuing operations, net noncontrolling interests and accrued preferred stock dividends	$	(68,070)	$	(107,559)	$	(139,432)	$	(252,680)
Loss from discontinued operations	(56,935)		(176,568)		(172,478)		(235,619)
Net loss attributable to Bright Health Group, Inc. common shareholders	$	(125,005)	$	(284,127)	$	(311,910)	$	(488,299)
Weighted-average number of shares outstanding used to compute net loss per share attributable to common stockholders, basic and diluted	7,962		7,865		7,928		7,862
Basic and diluted loss per share attributable to Bright Health Group, Inc. common shareholders
Continuing operations	$	(8.55)	$	(13.68)	$	(17.59)	$	(32.14)
Discontinued operations	$	(7.15)	$	(22.45)	$	(21.76)	$	(29.97)
Net loss per share attributable to common stockholders, basic and diluted	$	(15.70)	$	(36.13)	$	(39.35)	$	(62.11)

The following outstanding shares of potentially dilutive securities were excluded from the computation of diluted net loss per share because including them would have had an anti-dilutive effect for the six months ended June 30 (in thousands):


	Six Months Ended June 30,
	2023	2022
Redeemable convertible preferred stock (as converted to common stock)	4,081	2,112
Stock options to purchase common stock	720	853
Restricted stock units	1,108	458
Total	5,909	3,423